A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
Antibiotics not helpful for cough due to lower respiratory tract infection
Apr 25, 2024
Despite patient beliefs, no effect was seen on the severity or duration of the cough.
Use of acid-suppression therapy linked to migraine, severe headache
Apr 26, 2024
Adjusted odds ratios of 1.70, 1.40 and 1.30 were seen for proton pump inhibitors, H2 receptor antagonists and generic antacids, respectively.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease
Apr 11, 2024
The infusion increases on time without troublesome dyskinesia and reduces daily off time.